Insider Selling: Tabula Rasa HealthCare Inc (TRHC) Director Sells 15,000 Shares of Stock

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Gordon Tunstall sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, December 8th. The stock was sold at an average price of $25.85, for a total transaction of $387,750.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Tabula Rasa HealthCare Inc (NASDAQ TRHC) traded down $0.01 during midday trading on Monday, reaching $28.59. The company’s stock had a trading volume of 153,525 shares, compared to its average volume of 105,992. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.73 and a quick ratio of 0.66. Tabula Rasa HealthCare Inc has a 52 week low of $11.59 and a 52 week high of $36.80.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Monday, November 6th. The company reported $0.08 EPS for the quarter, topping the Zacks’ consensus estimate of $0.06 by $0.02. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The business had revenue of $33.27 million during the quarter, compared to the consensus estimate of $31.76 million. During the same period in the previous year, the company posted $0.06 earnings per share. The business’s revenue for the quarter was up 37.6% on a year-over-year basis. sell-side analysts forecast that Tabula Rasa HealthCare Inc will post 0.05 earnings per share for the current fiscal year.

Institutional investors have recently made changes to their positions in the company. Hood River Capital Management LLC boosted its holdings in Tabula Rasa HealthCare by 7.5% in the second quarter. Hood River Capital Management LLC now owns 825,225 shares of the company’s stock valued at $12,420,000 after purchasing an additional 57,724 shares in the last quarter. Vanguard Group Inc. grew its holdings in Tabula Rasa HealthCare by 13.4% during the second quarter. Vanguard Group Inc. now owns 236,964 shares of the company’s stock worth $3,566,000 after acquiring an additional 27,997 shares during the period. Boston Partners grew its holdings in Tabula Rasa HealthCare by 17.1% in the second quarter. Boston Partners now owns 235,180 shares of the company’s stock valued at $3,540,000 after purchasing an additional 34,360 shares during the last quarter. Pier Capital LLC acquired a new stake in Tabula Rasa HealthCare in the third quarter valued at $4,151,000. Finally, Wasatch Advisors Inc. acquired a new stake in Tabula Rasa HealthCare in the third quarter valued at $4,047,000. 31.85% of the stock is owned by institutional investors and hedge funds.

TRHC has been the subject of a number of recent research reports. Piper Jaffray Companies reissued a “buy” rating and set a $29.00 price target on shares of Tabula Rasa HealthCare in a research report on Tuesday, October 24th. UBS raised their price target on shares of Tabula Rasa HealthCare from $18.00 to $25.00 and gave the stock a “buy” rating in a research report on Wednesday, August 30th. BidaskClub cut shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, December 6th. Zacks Investment Research cut shares of Tabula Rasa HealthCare from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 10th. Finally, ValuEngine raised shares of Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a research note on Saturday, September 30th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $28.25.

WARNING: This report was first reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this report on another website, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2017/12/11/insider-selling-tabula-rasa-healthcare-inc-trhc-director-sells-15000-shares-of-stock.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply